SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001415889-18-001093
Filing Date
2018-07-09
Accepted
2018-07-09 08:00:16
Documents
3
Period of Report
2018-07-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k-07092018_080702.htm 8-K 33704
2 ex99-07092018_080703.htm EX-99 12904
3 graphic-07092018_010744.jpg GRAPHIC 10602
  Complete submission text file 0001415889-18-001093.txt   62641
Mailing Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121
Business Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001109196 (see all company filings)

IRS No.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37861 | Film No.: 18943422
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1